Reconsidering Treatment Effects in Sequential Ranibizumab-Dexamethasone Therapy for Retinal Vein Occlusion [Letter].

dexamethasone - Generic mfg.

Lucentis (ranibizumab) - Roche, Novartis

Reconsidering Treatment Effects in Sequential Ranibizumab-Dexamethasone Therapy for Retinal Vein Occlusion [Letter]. (PubMed, Drug Des Devel Ther) - Oct 14, 2026 - No abstract available
Journal • Retinal Vein Occlusion

http://www.ncbi.nlm.nih.gov/pubmed/42866563

Jing Chen

Oct 14, 2026